Publication
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies
Journal Paper/Review - Apr 25, 2013
Franke Andre, Büning Carsten, Duerr Richard H, Nöthen Markus M, Wang Jun, Vatn Morten H, Mathew Christopher G, Sanderson Jeremy D, Rutgeerts Paul, Vermeire Severine, McArdle Wendy L, Strachan David P, Wijmenga Cisca, Sans Miquel, Brand Stephan, Glas Jürgen, Parkes Miles, Schreiber Stefan, Rosenstiel Philip, Subramani Suresh, Karlsen Tom H, Nothnagel Michael, Daly Mark J, D'Amato Mauro, Halfvarson Jonas, Annese Vito, Latiano Anna, Illig Thomas, Winkelmann Juliane, Ponsioen Cyriel Y, Weersma Rinse K, Nikolaus Susanna, Liu Xiao, Doncheva Nadezhda T, Skieceviciene Jurgita, Rivas Manuel A, Keller Andreas, Ellinghaus Eva, Bromberg Yana, Stade Björn, Jiang Tao, Till Andreas, Lipinski Simone, Zeissig Sebastian, Zhang Hu, Liu Qing, Jiang Fuman, Krawczak Michael, Kayser Manfred, Kupcinskas Limas, Vogel Ulla, Andersen Vibeke, Lee James, Berzuini Carlo R, Goodall Jane, Boehm Bernhard O, Häsler Robert, Albrecht Mario, Mayr Gabriele, Forster Michael, Ellinghaus David
Units
PubMed
Doi
Citation
Type
Journal
Publication Date
Issn Electronic
Pages
Brief description/objective
BACKGROUND & AIMS
Genome-wide association studies (GWAS) have identified 140 Crohn's disease (CD) susceptibility loci. For most loci, the variants that cause disease are not known and the genes affected by these variants have not been identified. We aimed to identify variants that cause CD through detailed sequencing, genetic association, expression, and functional studies.
METHODS
We sequenced whole exomes of 42 unrelated subjects with CD and 5 healthy subjects (controls) and then filtered single nucleotide variants by incorporating association results from meta-analyses of CD GWAS and in silico mutation effect prediction algorithms. We then genotyped 9348 subjects with CD, 2868 subjects with ulcerative colitis, and 14,567 control subjects and associated variants analyzed in functional studies using materials from subjects and controls and in vitro model systems.
RESULTS
We identified rare missense mutations in PR domain-containing 1 (PRDM1) and associated these with CD. These mutations increased proliferation of T cells and secretion of cytokines on activation and increased expression of the adhesion molecule L-selectin. A common CD risk allele, identified in GWAS, correlated with reduced expression of PRDM1 in ileal biopsy specimens and peripheral blood mononuclear cells (combined P = 1.6 × 10(-8)). We identified an association between CD and a common missense variant, Val248Ala, in nuclear domain 10 protein 52 (NDP52) (P = 4.83 × 10(-9)). We found that this variant impairs the regulatory functions of NDP52 to inhibit nuclear factor κB activation of genes that regulate inflammation and affect the stability of proteins in Toll-like receptor pathways.
CONCLUSIONS
We have extended the results of GWAS and provide evidence that variants in PRDM1 and NDP52 determine susceptibility to CD. PRDM1 maps adjacent to a CD interval identified in GWAS and encodes a transcription factor expressed by T and B cells. NDP52 is an adaptor protein that functions in selective autophagy of intracellular bacteria and signaling molecules, supporting the role of autophagy in the pathogenesis of CD.